Skip to content
Cultural Foundation
Author:
Tarsus Pharmaceuticals, Inc
Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth
August 6, 2026
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position
August 6, 2026
Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing
August 6, 2026
Tarsus to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
August 5, 2026
Tarsus Pharmaceuticals Announces Executive Leadership Transition as Company Advances Next Phase of Growth
July 13, 2026
Tarsus Advances Eye Care Leadership Strategy with Acquisition of iRenix Medical and Late-Stage Asset IRX-101
July 8, 2026
Tarsus to Participate in Upcoming Investor Conferences
May 28, 2026
Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans
May 14, 2026
Tarsus to Participate in Upcoming Investor Conferences
May 7, 2026
Tarsus Reports First Quarter 2026 Financial Results and Recent Business Achievements
May 6, 2026
1
2
Next Page
→